$0.4001
-0.02-4.76%
At close: -
$0.4098
0.009702.42%
After Hours: Dec 20, 4:55 PM EDT
Comments
Loading...
ImmunoPrecise Antibodies (NASDAQ:IPA) Stock, Earnings Estimates, EPS, And Revenue
ImmunoPrecise Antibodies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$-0.090
Quarterly Revenue Estimate
$5M
Annual Revenue
(as of Oct 31)
(as of Oct 31)
$24.1M
Analyze the earnings history of ImmunoPrecise Antibodies using advanced sorting and filters.
Data brought to you by Benzinga APIs
ImmunoPrecise Antibodies (IPA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-12-10 | $-0.07 | $-0.05 | -40.0 % |
| Jun 2024 | 2024-09-16 | $-0.11 | $-0.08 | -37.5 % |
| Jun 2024 | 2024-07-29 | $-0.58 | $-0.08 | -625.0 % |
| Dec 2023 | 2024-03-14 | $-0.08 | $-0.07 | -14.3 % |
ImmunoPrecise Antibodies (IPA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-12-10 | $4.49M | $5.11M | -12.2 % |
| Jun 2024 | 2024-09-16 | $3.87M | $4.96M | -22.0 % |
| Jun 2024 | 2024-07-29 | $4.72M | $4.72M | 0.02 % |
| Dec 2023 | 2024-03-14 | $4.56M | $4.50M | 1.22 % |
FAQ
When is ImmunoPrecise Antibodies (NASDAQ:IPA) reporting earnings?
ImmunoPrecise Antibodies (IPA) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on December 10, 2024 for Q2.
What were the latest earnings per share (EPS) for ImmunoPrecise Antibodies (NASDAQ:IPA)?
The Actual EPS was $-0.07, which missed the estimate of $-0.05.
What were ImmunoPrecise Antibodies’s (NASDAQ:IPA) revenues?
The Actual Revenue was $4.5M, which missed the estimate of $5.1M.
Browse earnings estimates, EPS, and revenue on all stocks.